Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2011 1
2012 1
2013 3
2014 2
2015 1
2016 3
2017 2
2018 4
2019 5
2020 5
2021 7
2022 12
2023 9
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Results by year

Filters applied: . Clear all
Page 1
BECC438b TLR4 agonist supports unique immune response profiles from nasal and muscular DTaP pertussis vaccines in murine challenge models.
DeJong MA, Wolf MA, Bitzer GJ, Hall JM, Fitzgerald NA, Pyles GM, Huckaby AB, Petty JE, Lee K, Barbier M, Bevere JR, Ernst RK, Damron FH. DeJong MA, et al. Among authors: barbier m. Infect Immun. 2024 Mar 12;92(3):e0022323. doi: 10.1128/iai.00223-23. Epub 2024 Feb 7. Infect Immun. 2024. PMID: 38323817 Free PMC article.
Intranasal challenge with B. pertussis leads to more severe disease manifestations in mice than aerosol challenge.
Weaver KL, Bitzer GJ, Wolf MA, Pyles GM, DeJong MA, Dublin SR, Huckaby AB, Gutierrez MP, Hall JM, Wong TY, Warden M, Petty JE, Witt WT, Cunningham C, Sen-Kilic E, Damron FH, Barbier M. Weaver KL, et al. Among authors: barbier m. PLoS One. 2023 Nov 2;18(11):e0286925. doi: 10.1371/journal.pone.0286925. eCollection 2023. PLoS One. 2023. PMID: 37917623 Free PMC article.
Monoclonal antibodies against lipopolysaccharide protect against Pseudomonas aeruginosa challenge in mice.
Kang J, Mateu-Borrás M, Monroe HL, Sen-Kilic E, Miller SJ, Dublin SR, Huckaby AB, Yang E, Pyles GM, Nunley MA, Chapman JA, Amin MS, Damron FH, Barbier M. Kang J, et al. Among authors: barbier m. Front Cell Infect Microbiol. 2023 Jun 22;13:1191806. doi: 10.3389/fcimb.2023.1191806. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37424774 Free PMC article.
In Vivo Genome-Wide Gene Expression Profiling Reveals That Haemophilus influenzae Purine Synthesis Pathway Benefits Its Infectivity within the Airways.
Euba B, Gil-Campillo C, Asensio-López J, López-López N, Sen-Kilic E, Díez-Martínez R, Burgui S, Barbier M, Garmendia J. Euba B, et al. Among authors: barbier m. Microbiol Spectr. 2023 Jun 15;11(3):e0082323. doi: 10.1128/spectrum.00823-23. Epub 2023 May 17. Microbiol Spectr. 2023. PMID: 37195232 Free PMC article.
Development of an anti-Pseudomonas aeruginosa therapeutic monoclonal antibody WVDC-5244.
Horspool AM, Sen-Kilic E, Malkowski AC, Breslow SL, Mateu-Borras M, Hudson MS, Nunley MA, Elliott S, Ray K, Snyder GA, Miller SJ, Kang J, Blackwood CB, Weaver KL, Witt WT, Huckaby AB, Pyles GM, Clark T, Al Qatarneh S, Lewis GK, Damron FH, Barbier M. Horspool AM, et al. Among authors: barbier m. Front Cell Infect Microbiol. 2023 Apr 14;13:1117844. doi: 10.3389/fcimb.2023.1117844. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37124031 Free PMC article.
Molecular engineering of a cryptic epitope in Spike RBD improves manufacturability and neutralizing breadth against SARS-CoV-2 variants.
Rodriguez-Aponte SA, Dalvie NC, Wong TY, Johnston RS, Naranjo CA, Bajoria S, Kumru OS, Kaur K, Russ BP, Lee KS, Cyphert HA, Barbier M, Rao HD, Rajurkar MP, Lothe RR, Shaligram US, Batwal S, Chandrasekaran R, Nagar G, Kleanthous H, Biswas S, Bevere JR, Joshi SB, Volkin DB, Damron FH, Love JC. Rodriguez-Aponte SA, et al. Among authors: barbier m. Vaccine. 2023 Jan 27;41(5):1108-1118. doi: 10.1016/j.vaccine.2022.12.062. Epub 2022 Dec 29. Vaccine. 2023. PMID: 36610932 Free PMC article.
55 results